Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2000

View Archived Issues

Genetic cause of lymphedema discovered by U. of Pittsburgh researchers

Company Profile: Genteric

Randomized study of tafenoquine as malaria chemoprophylaxis

Vical licenses naked DNA technology to Aventis

Vasopressin V1a receptor antagonist aids in prevention of dysmenorrhea

Atrix receives Canadian marketing approval for Atridox

Angiostatin combined with radiation therapy enters phase I trials

Alizyme successfully concludes phase Ia trial of ATL-962 for treatment of obesity

Final results of phase II study of Synsorb Cd reported by Synsorb Biotech

Novel vaccine appears to clear amyloid plaques from the brain and prevent their formation

New benzazepine selectively targets tumor cells and induces G2/M arrest and apoptosis

Chemoprotective effects of KF-41399 demonstrated in nimustine-treated mice

Novel approach to AD discussed at World Alzheimer Congress: intranasal ADNP-derived peptide

FDA advisory committee recommends approval of LeuTech for imaging infection

ST-6: a new cardioprotective agent hypothesized to block sodium overload during ischemia

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

Tumor antigen-specific chimeric proteins from Idec promote antitumor immune response

Hydrazine-based inhibitors of TNF-alpha release described by Roche

Patent recently issued to BASF covering new PARP inhibitors and their use

Immunosuppressive humanized antibodies designed by LG Chemical

Novel cystatin protein expressed in testis and potential uses thereof described by ZymoGenetics

Shionogi presents new cephem antibiotics

Japanese laboratories discover naturally produced chymase inhibitors

Orally active human elastase inhibitors developed under collaborative Cortech-Ono effort

Maxim licenses caspase-activating anticancer compounds to BioChem Pharma

KS Biomedix seeks approval to begin clinical trials of anticancer antibody

Axokine phase II obesity trial completes enrollment

CINP news: AC-5216 appears superior to diazepam in the treatment of anxiety and depression

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...